Bottom line: All of the vaccines authorized for use in the U.S. are still very effective against the variant and greatly reduce the risk of severe disease, hospitalization or death.
The CDC’s Advisory Committee on Immunization Practices decided to wait another seven to ten days before making any safety recommendations about the Johnson & Johnson vaccine.
A link to rare blood clots have caused the rollout of the AstraZeneca and Johnson & Johnson Covid-19 vaccines to pause around the world. This is what scientists say about the risks and the next steps.